Publication | Closed Access

Erythropoietin protects the inner blood–retinal barrier by inhibiting microglia phagocytosis via Src/Akt/cofilin signalling in experimental diabetic retinopathy

InflammationMicroglia PhagocytosisDiabetic RetinopathyOcular DiseaseRetinaOphthalmologyMedicineExperimental Diabetic RetinopathyDiabetesImmunologyNeuroprotectionRetinal TherapiesInner Blood–retinal BarrierNeuroimmunologyCell BiologyCell SignalingOxidative StressNeuroinflammation